Drug intelligence / Profile preview

sennosides (Assistance publique - Hôpitaux de Paris)

Development stage
Unknown
Lead developer
Assistance publique - Hôpitaux de Paris
Modality
Small Molecules
Administration
Oral
01

Overview

Sennosides are a class of anthraquinone stimulant laxatives derived from the Senna plant (*Senna alexandrina*). They act as prodrugs that are converted by colonic bacteria into active rheinanthrones. These metabolites stimulate the myenteric plexus, leading to increased colonic motility and peristalsis, while also inhibiting water and electrolyte absorption and promoting their secretion into the intestinal lumen. In the clinical trial context of the COLONPREP study (NCT02744456) sponsored by Assistance Publique - Hôpitaux de Paris, sennosides are utilized as the mechanical bowel preparation (MBP) agent. The study evaluates the efficacy of sennosides-based MBP, alone or in combination with oral antibiotics, for the prevention of surgical site infections (SSI) in patients undergoing elective laparoscopic surgery for colon cancer.

Brand names
SenokotEx-LaxPursennidSenna-LaxSennaPromptSenna-S
Other names
Senna glycosidesSennoside ASennoside BSennoside A+BAnthraquinone glycosides
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on sennosides (Assistance publique - Hôpitaux de Paris).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sennosides (Assistance publique - Hôpitaux de Paris).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call